nmdcat.online
BS Nursing Epidemiology
nmdcat.online June 6, 2026

183. A new medicinal drug is being tested for a very rare disease, where it’s unethical to withhold treatment from a placebo group. What technical alternative study design might be considered?

A. Cross-sectional study.
B. Case-control study.
C. Historical cohort study.
D. Single-arm trial or compassionate use program.
✓

📖 Additional Information

  • Cross-sectional study.
  • Case-control study.
  • Historical cohort study.
  • Single-arm trial or compassionate use program.

🔗 Share This Question

Facebook Twitter LinkedIn WhatsApp

🧭 Navigate Questions

Previous Question

182. What technical term describes the systematic review and statistical combination of data from multiple independent studies addressing the same question?

Next Question

184. A study finds a statistical association between exposure to a new chemical and cancer, but the dose-response relationship is not observed (i.e., higher exposure does not lead to higher risk). What critical Bradford Hill criterion is weakened?

Back to All Questions

🔗 Related MCQs

Exudate does NOT contain:
June 6, 2026
Rubor refers to:
June 6, 2026
Necrotic tissue refers to:
June 6, 2026
True about endotoxins:
June 6, 2026
Bacteria avoiding WBC engulfment:
June 6, 2026

Categories

View all →